CA2433018A1 — Thiazolyl inhibitors of tec family tyrosine kinases
Assigned to Bristol Myers Squibb Co · Expires 2002-06-27 · 24y expired
What this patent protects
Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associateddisorders such as cancer, immunologic disorders and allergic disorders.
USPTO Abstract
Novel thiazolyl compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of Tec family tyrosine kinase-associateddisorders such as cancer, immunologic disorders and allergic disorders.
Drugs covered by this patent
- Velsipity (Etrasimod Arginine) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.